Target intelligence / Profile preview

Solute carrier family 25 member 5 pseudogene 2 (SLC25A5P2)

Target: SLC25A5P2
Molecular classification: Pseudogene, Member of the solute carrier family 25 (mitochondrial carrier) by sequence homology; but not a functional transporter

Overview

Solute carrier family 25 member 5 pseudogene 2 (SLC25A5P2, LOC344371) is a non-functional DNA sequence related to the solute carrier family 25 member 5, which encodes mitochondrial adenine nucleotide carriers. SLC25A5P2 is classified as a pseudogene, meaning it resembles a protein-coding gene but contains mutations that preclude expression of a functional protein. While some pseudogenes are transcribed or may play minor roles in RNA-based regulation, there is no evidence of direct biological or therapeutic relevance for SLC25A5P2 itself.

Other names: SLC25A5P2LOC344371

Mechanism of action

None (no drugs target this pseudogene)

Biological functions

None established; as a pseudogene, it does not encode a functional proteinPseudogenes, in general, can sometimes regulate coding genes via RNA mechanisms (e.g., acting as microRNA decoys or sources of small interfering RNAs, but no direct evidence for SLC25A5P2 specific activity)

Disease associations

None established for SLC25A5P2 itselfIn general, pseudogenes have been found to participate in regulatory networks and may be involved in cancer or other disease pathways, but there is no evidence for SLC25A5P2 specifically

Safety considerations

None (as it is not a protein target or therapeutic target)

Interacting drugs

None (pseudogene; does not produce a druggable protein target)

Biomarkers

None established for patient selection or efficacy monitoring

Beyond the preview

Go deeper on Solute carrier family 25 member 5 pseudogene 2 (SLC25A5P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Solute carrier family 25 member 5 pseudogene 2 (SLC25A5P2).

Explore the full profile